医療診断用人工知能(AI)の世界市場予測(~2028):モダリティ別、用途別、エンドユーザー別

【英語タイトル】Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (CT, X-Ray, MRI, Ultrasound), Application (IVD, Radiology, CNS, CVS, Ob/Gyn), User (Hospital, Labs), Unmet Need, Key Stakeholders & Buying Criteria - Global Forecast to 2028

MarketsandMarketsが出版した調査資料(HIT7875-23)・商品コード:HIT7875-23
・発行会社(調査会社):MarketsandMarkets
・発行日:2023年10月19日
・ページ数:327
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:IT
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
“世界の医療診断用人工知能(AI)市場は、2023年の13億米ドルから2028年には37億米ドルに達し、予測期間中のCAGRは23.2%と予測”医療診断用人工知能(AI)の採用は、AIベースの技術の取り込みを促進するための様々な政府イニシアチブの成長、作業負荷を軽減するために放射線科医によってより多く使用されているAIソリューション、業界を超えたパートナーシップ&コラボレーションの数の増加などの要因のために速いペースで上昇しています。
しかし、訓練されたAI労働力の不足や不安定な規制は、市場の成長を抑制する要因になると予想されます。

“サービス分野は2023年から2028年にかけて最も高い成長率が見込まれる”
コンポーネント別に見ると、医療診断用人工知能(AI)市場はソフトウェア、ハードウェア、サービスに分類されます。2022年にはソフトウェア分野がこの市場で最大のシェアを占め、サービス分野は2023年から2028年にかけてより高いCAGRで成長すると推定されています。ソフトウェア・ソリューションは、人手不足と画像スキャン量の増加という課題にもかかわらず、医療提供者に競争優位性を提供します。

“生体内診断セグメントは、2023年に世界の医療診断用人工知能(AI)市場で最大のシェアを占めると推定”
アプリケーション別に見ると、医療診断用人工知能(AI)市場は生体内診断と体外診断に分けられます。2023年には、生体内診断セグメントがこの市場で最大のシェアを占めると予測されています。その要因としては、開業医によるAIソリューションの導入が進んでいること、これらのソリューションがヒューマンエラーを減少させ、治療効果を高めることに常に役立っていることなどが挙げられます。しかし、体外診断セグメントは予測期間中に最も高い成長を記録すると予測されています。AIソリューションは、分析およびデータ解釈時間の短縮に役立つため、体外診断アプリケーションへの採用が増加しています。

“2023年、医療診断用人工知能(AI)世界市場で病院セグメントが最大シェアを占めると推定”
エンドユーザー別に見ると、医療診断用人工知能(AI)市場は、病院、画像診断センター、診断ラボ、その他のエンドユーザーに分けられます。2023年には、病院セグメントがこの市場で最大の市場シェアを占めると予測されています。患者ケアの質を高めるために病院での低侵襲処置の採用が増加していることや、ワークフローを改善するために高度な画像モダリティの適用が進んでいることなどが要因でした。

“北米が2023年に医療診断用人工知能(AI)市場を支配する”
地域別に見ると、医療診断用人工知能(AI)市場は、主に北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカの5つの地域セグメントに区分されています。2023年には、北米がこの市場で最大の市場シェアを占めると推定されます。しかし、アジア太平洋市場は2023年から2028年にかけて最も高いCAGRを記録すると予測されています。癌の有病率の増加、有利な政府のイニシアチブの実施などの要因です。

供給側一次インタビューの内訳は以下の通りです(企業タイプ別、呼称別、地域別):
- 企業タイプ別: 企業タイプ別:ティア1(40%)、ティア2(30%)、ティア3(30%)
- 役職別 Cレベル(27%)、ディレクターレベル(18%)、その他(55%)
- 地域別 北米 (40%)、ヨーロッパ (20%)、アジア太平洋 (30%)、その他地域 (10%)

同市場における主なプレーヤーには、Microsoft (US), NVIDIA Corporation (US), Merative (US), Intel Corporation (US), Google (US), Siemens Healthineers (Germany), GE HealthCare (US), Digital Diagnostics Inc. (US), Advanced Micro Devices, Inc. (US), InformAI (US), HeartFlow, Inc. (US), Enlitic, Inc. (US), isometric (Belgium), Aidence (Netherlands), Butterfly Network, Inc. (US), Nano-X Imaging LTD. (Israel), Viz.ai, Inc (US), Quibim (Spain), Qure.ai (India), Therapixel (France), Aidoc (US), Koninklijke Philips N.V. (Netherlands), Lunit, Inc. (South Korea), EchoNous, Inc. (US), and Brainomix (UK)などが含まれます。

調査範囲:
- 医療診断用人工知能(AI)市場をコンポーネント、用途、エンドユーザー、地域別に調査しています。
- 市場成長に影響を与える要因(促進要因、阻害要因、機会、課題など)を分析しています。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- 当レポートでは、医療診断用人工知能(AI)市場の成長動向、展望、市場全体への貢献に関してミクロ市場を調査しています。
- 主要5地域に関して市場セグメントの収益を予測しています。

レポート購入の主な利点:
本レポートは、市場全体およびサブセグメントの収益数値に最も近い近似値に関する情報を提供することで、本市場のリーダー/新規参入者を支援します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が医療診断用人工知能(AI)市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します:
- 主な推進要因(ビッグデータの流入、業界を超えたパートナーシップとコラボレーションの拡大、放射線科医の作業負担を軽減するためのAIソリューションの採用増加、AIベースの技術を推進するための政府のイニシアティブの高まり、AIベースの新興企業に対する資金提供の可能性)、阻害要因(不十分なAI労働力、医療ソフトウェアに関する曖昧な規制ガイドライン)、機会(未開拓の新興市場、人間を意識したAIシステムの開発への注目の高まり)、課題(AIベースの技術の採用に消極的、予算の制約、構造化されていない医療データ、データプライバシーに関する懸念、限られた相互運用性)の分析しました。
- 市場への浸透: 医療診断用人工知能(AI)の世界市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報を掲載しています。当レポートでは、この市場をコンポーネント別、アプリケーション別、エンドユーザー別に分析しています。
- サービスの強化/革新: 医療診断用人工知能(AI)の世界市場における今後の動向に関する詳細な洞察を掲載しています。
- 市場開発: コンポーネント別、アプリケーション別、エンドユーザー別の有利な新興市場に関する包括的情報を掲載しています。
- 市場の多様化: 医療診断用AIの世界市場における新サービスやサービス強化、成長地域、最新動向、投資に関する詳細情報を掲載しています。
- 競合評価: 医療診断用AIの世界市場における主要企業の市場シェア、成長戦略、製品提供、企業評価象限、能力を詳細に評価しています。
❖ レポートの概要 ❖

1 イントロダクション
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 世界の医療診断用人工知能(AI)市場分析:コンポーネント別
7 世界の医療診断用人工知能(AI)市場分析:用途別
8 世界の医療診断用人工知能(AI)市場分析:エンドユーザー別
9 世界の医療診断用人工知能(AI)市場分析:地域別
10 競争状況
11 企業情報
12 付録

❖ レポートの目次 ❖

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
1.2.1 INCLUSIONS AND EXCLUSIONS 45
1.3 MARKET SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 YEARS CONSIDERED 46
1.3.3 CURRENCY CONSIDERED 47
1.4 STAKEHOLDERS 47
1.5 SUMMARY OF CHANGES 47
1.6 RECESSION IMPACT 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
FIGURE 1 RESEARCH DESIGN 49
2.1.1 SECONDARY DATA 50
2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY DATA 51
FIGURE 2 PRIMARY SOURCES 52
2.1.2.1 Key data from primary sources 53
2.1.2.2 Key industry insights 53
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 54
2.2 MARKET SIZE ESTIMATION 54
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 54
FIGURE 5 MARKET SIZE ESTIMATION 55
TABLE 1 FACTOR ANALYSIS 56
FIGURE 6 AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 57
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 57
FIGURE 8 TOP-DOWN APPROACH 58
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 59
FIGURE 9 DATA TRIANGULATION METHODOLOGY 59
2.4 ASSUMPTIONS 60
2.5 LIMITATIONS 60
2.5.1 SCOPE-RELATED LIMITATIONS 60
2.5.2 METHODOLOGY-RELATED LIMITATIONS 60
2.6 RISK ASSESSMENT 61
TABLE 2 RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET 61
2.7 AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS 61
3 EXECUTIVE SUMMARY 62
FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 62
FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 63
FIGURE 12 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 63
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET 64
4 PREMIUM INSIGHTS 65
4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW 65
FIGURE 14 RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF BIG DATA TO DRIVE MARKET 65
4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2022) 66
FIGURE 15 IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA IN 2022 66
4.3 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 16 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE 66
4.4 AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX 67
FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 67
4.5 AI IN MEDICAL DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 67
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.1.1 DRIVERS 69
5.1.1.1 Influx of big data 69
5.1.1.2 Growing cross-industry partnerships & collaborations 69
5.1.1.3 Increasing demand for AI-based solutions to reduce work pressure on radiologists 70
5.1.1.4 Rising government initiatives to support AI-based technologies 70
5.1.1.5 Availability of funding for AI-based startups 71
5.1.2 RESTRAINTS 72
5.1.2.1 Inadequate AI workforce and ambiguous regulatory guidelines for medical software 72
5.1.3 OPPORTUNITIES 72
5.1.3.1 Untapped emerging markets 72
5.1.3.2 Increasing focus on developing human-aware AI systems 73
5.1.4 CHALLENGES 73
5.1.4.1 Reluctance to adopt AI-based technologies 73
5.1.4.2 Budgetary constraints 74
5.1.4.3 Unstructured healthcare data 74
5.1.4.4 Data privacy concerns 74
5.1.4.5 Limited interoperability 75
5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 75
FIGURE 20 REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS 75
5.3 VALUE CHAIN ANALYSIS 75
FIGURE 21 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN 76
5.3.1 UPSTREAM 76
5.3.2 MID-STREAM 77
5.3.3 DOWNSTREAM 77
5.4 ECOSYSTEM MAPPING 77
FIGURE 22 AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM 77
5.4.1 ROLE IN ECOSYSTEM 78
5.5 CASE STUDIES 79
5.5.1 MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM 79
5.5.2 RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES 79
5.5.3 NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING 79
5.5.4 ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND 80
5.5.5 WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS 80
5.6 TECHNOLOGY ANALYSIS 81
5.6.1 MACHINE LEARNING 81
5.6.2 NATURAL LANGUAGE PROCESSING 81
5.6.3 COMPUTER VISION 81
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 81
5.7 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 4 AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.7.1 THREAT OF NEW ENTRANTS 83
5.7.2 THREAT OF SUBSTITUTES 83
5.7.3 BARGAINING POWER OF SUPPLIERS 83
5.7.4 BARGAINING POWER OF BUYERS 83
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 84
5.8 INDUSTRY TRENDS 84
5.8.1 ARTIFICIAL INTELLIGENCE IN HEALTHCARE 84
5.8.1.1 Key to AI in Healthcare: Data 84
5.8.1.2 AR and MR in Healthcare Settings 84
5.8.1.3 Healthcare Privacy and Security in 2022 84
5.8.1.4 Growing demand for AI among companies offering at-home IVD testing services 85
5.9 TRADE ANALYSIS 85
FIGURE 23 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND) 85
FIGURE 24 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND) 86
5.10 TARIFF AND REGULATORY ANALYSIS 86
5.10.1 TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE 86
TABLE 5 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022 86
TABLE 6 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022 86
TABLE 7 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020 87
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
5.10.3 NORTH AMERICA 90
FIGURE 25 ALGORITHMS CLEARED BY US FDA, 2008 TO 2023 91
5.10.3.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA) 91
5.10.3.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH) 91
5.10.3.3 Consumer Privacy Protection Act of 2017 91
5.10.3.4 National Cybersecurity Protection Advancement Act of 2015 91
5.10.3.5 Future of Life Institute’s Asilomar AI Principles 92
5.10.4 EUROPE 92
5.10.4.1 European Medical Devices Regulation (EU) 2017/745 and In-vitro Diagnostic Medical Devices Regulation (EU) 2017/746, in combination with General Data Protection Regulation 2016/679 92
5.10.4.2 AI Act (Artificial Intelligence Act) 92
5.10.5 ASIA PACIFIC 93
5.10.5.1 Cybersecurity Law of the People’s Republic of China 93
5.10.6 REST OF THE WORLD 93
5.10.6.1 Protection of Personal Information Act 93
5.11 PRICING ANALYSIS 94
FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR) 94
TABLE 12 AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE 94
5.11.1 AVERAGE SELLING PRICE TREND 95
5.12 PATENT ANALYSIS 95
5.12.1 PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS 95
FIGURE 27 PATENT PUBLICATION TRENDS (2019-2023) 95
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023) 96
TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET 96
5.13 KEY CONFERENCES AND EVENTS (2023–2024) 98
TABLE 14 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 98
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 99
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS 99
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 100
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 100
5.14.2 BUYING CRITERIA 100
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 100
TABLE 17 KEY BUYING CRITERIA FOR END USERS 101
5.15 UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET 101
TABLE 18 AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS 101
5.16 END-USER EXPECTATIONS 102
TABLE 19 AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS 102
5.17 REIMBURSEMENT SCENARIO 103
TABLE 20 SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE 104
TABLE 21 DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT 104
5.17.1 REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY 105
6 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT 106
6.1 INTRODUCTION 107
TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 107
TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 107
6.2 SOFTWARE 107
6.2.1 USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS 107
TABLE 24 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 108
TABLE 25 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 109
6.3 SERVICES 109
6.3.1 RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH 109
TABLE 26 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 110
TABLE 27 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 110
6.4 HARDWARE 111
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH 111
TABLE 28 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 111
TABLE 29 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 111
TABLE 30 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 112
TABLE 31 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 112
6.4.2 PROCESSORS 113
TABLE 32 PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 113
TABLE 33 PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 113
TABLE 34 PROCESSORS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 114
TABLE 35 PROCESSORS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 114
6.4.2.1 MPU 115
6.4.2.1.1 MPUs to hold largest share of processors market 115
TABLE 36 MPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 115
TABLE 37 MPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 116
6.4.2.2 GPU 116
6.4.2.2.1 GPUs play crucial role in enhancing accuracy and efficacy of imaging 116
TABLE 38 GPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 117
TABLE 39 GPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 117
6.4.2.3 FPGA 118
6.4.2.3.1 Wide usage potential to drive demand 118
TABLE 40 FPGA MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 118
TABLE 41 FPGA MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 119
6.4.2.4 ASIC 119
6.4.2.4.1 Rapid operations to support end-user demand 119
TABLE 42 ASIC MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 120
TABLE 43 ASIC MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 120
6.4.3 MEMORY 121
6.4.3.1 Development of high-bandwidth memory for AI applications to drive market 121
TABLE 44 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 121
TABLE 45 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 122
6.4.4 NETWORKS 122
TABLE 46 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 122
TABLE 47 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 123
TABLE 48 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 123
TABLE 49 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 124
6.4.4.1 Adapters 124
6.4.4.1.1 Adapters to hold largest share of networks market 124
TABLE 50 ADAPTERS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 125
TABLE 51 ADAPTERS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 125
6.4.4.2 Switches 126
TABLE 52 SWITCHES MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 126
TABLE 53 SWITCHES MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 127
6.4.4.3 Interconnects 127
6.4.4.3.1 Need for efficient data transmission to drive market 127
TABLE 54 INTERCONNECTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 128
TABLE 55 INTERCONNECTS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 128
7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION 129
7.1 INTRODUCTION 130
TABLE 56 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 130
TABLE 57 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 130
7.2 IN VIVO DIAGNOSTICS 131
7.2.1 IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY 131
TABLE 58 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 131
TABLE 59 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 131
TABLE 60 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2017–2021 (USD MILLION) 132
TABLE 61 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2022–2028 (USD MILLION) 132
7.2.1.1 Radiology 133
7.2.1.1.1 AI-based diagnostic tools to reduce work pressure on radiologists 133
TABLE 62 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION) 133
TABLE 63 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION) 134
7.2.1.2 Cardiology 134
7.2.1.2.1 Rising complexities associated with CVD to drive market 134
TABLE 64 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION) 135
TABLE 65 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION) 135
7.2.1.3 Neurology 136
7.2.1.3.1 Increasing prevalence of critical brain disorders to drive market 136
TABLE 66 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2017–2021 (USD MILLION) 137
TABLE 67 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2028 (USD MILLION) 137
7.2.1.4 Obstetrics/Gynecology 138
7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market 138
TABLE 68 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017–2021 (USD MILLION) 138
TABLE 69 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022–2028 (USD MILLION) 139
7.2.1.5 Ophthalmology 139
7.2.1.5.1 Rising need for early detection & prevention of eye diseases to drive market 139
TABLE 70 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2017–2021 (USD MILLION) 140
TABLE 71 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2022–2028 (USD MILLION) 140
7.2.1.6 Other specialties 141
TABLE 72 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2017–2021 (USD MILLION) 141
TABLE 73 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2022–2028 (USD MILLION) 142
7.2.2 IN VIVO DIAGNOSTICS MARKET, BY MODALITY 142
TABLE 74 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 142
TABLE 75 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 143
TABLE 76 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2017–2021 (USD MILLION) 143
TABLE 77 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2022–2028 (USD MILLION) 144
7.2.2.1 CT 144
7.2.2.1.1 Rising availability of cardiac CT devices with AI solutions to drive market 144
TABLE 78 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017–2021 (USD MILLION) 145
TABLE 79 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022–2028 (USD MILLION) 145
7.2.2.2 X-ray 146
7.2.2.2.1 Innovative AI solutions for x-ray imaging by key players to drive market 146
TABLE 80 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2017–2021 (USD MILLION) 146
TABLE 81 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2022–2028 (USD MILLION) 147
7.2.2.3 MRI 147
7.2.2.3.1 Rising technological advancements to drive adoption of AI in MRI 147
TABLE 82 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2017–2021 (USD MILLION) 148
TABLE 83 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2022–2028 (USD MILLION) 148
7.2.2.4 Ultrasound 149
7.2.2.4.1 Increasing prevalence of ovarian cancer to boost demand 149
TABLE 84 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION) 149
TABLE 85 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2022–2028 (USD MILLION) 150
7.2.2.5 Other modalities 150
TABLE 86 FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING 150
TABLE 87 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2017–2021 (USD MILLION) 151
TABLE 88 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2022–2028 (USD MILLION) 151
7.3 IN VITRO DIAGNOSTICS 152
7.3.1 INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH 152
TABLE 89 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2017–2021 (USD MILLION) 152
TABLE 90 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2028 (USD MILLION) 153
8 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER 154
8.1 INTRODUCTION 155
TABLE 91 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 155
TABLE 92 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 155
8.2 HOSPITALS 156
8.2.1 INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET 156
TABLE 93 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2021 (USD MILLION) 156
TABLE 94 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2028 (USD MILLION) 157
8.3 DIAGNOSTIC IMAGING CENTERS 157
8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET 157
TABLE 95 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2017–2021 (USD MILLION) 158
TABLE 96 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2022–2028 (USD MILLION) 158
8.4 DIAGNOSTIC LABORATORIES 159
8.4.1 RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET 159
TABLE 97 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2021 (USD MILLION) 159
TABLE 98 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2028 (USD MILLION) 160
8.5 OTHER END USERS 160
TABLE 99 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2021 (USD MILLION) 161
TABLE 100 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2028 (USD MILLION) 161

9 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY REGION 162
9.1 INTRODUCTION 163
TABLE 101 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017–2021 (USD MILLION) 163
TABLE 102 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022–2028 (USD MILLION) 163
9.2 NORTH AMERICA 164
9.2.1 NORTH AMERICA: RECESSION IMPACT 164
FIGURE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT 165
TABLE 103 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 165
TABLE 104 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 166
TABLE 105 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 166
TABLE 106 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 166
TABLE 107 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 167
TABLE 108 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 167
TABLE 109 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 168
TABLE 110 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 168
TABLE 111 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 168
TABLE 112 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 169
TABLE 113 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 169
TABLE 114 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 169
TABLE 115 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 170
TABLE 116 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 170
TABLE 117 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 170
TABLE 118 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 171
TABLE 119 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 171
TABLE 120 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 171
9.2.2 US 172
9.2.2.1 Increasing volume of imaging procedures to drive market 172
TABLE 121 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 173
TABLE 122 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 173
TABLE 123 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 173
TABLE 124 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 174
TABLE 125 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 174
TABLE 126 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 175
TABLE 127 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 175
TABLE 128 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 175
TABLE 129 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 176
TABLE 130 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 176
TABLE 131 US: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 176
TABLE 132 US: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 177
TABLE 133 US: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 177
TABLE 134 US: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 177
TABLE 135 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 178
TABLE 136 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 178
9.2.3 CANADA 178
9.2.3.1 Research grants and improved academics in radiology to drive market 178
TABLE 137 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 179
TABLE 138 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 179
TABLE 139 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 179
TABLE 140 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 180
TABLE 141 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 180
TABLE 142 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 180
TABLE 143 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 181
TABLE 144 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 181
TABLE 145 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 181
TABLE 146 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 182
TABLE 147 CANADA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 182
TABLE 148 CANADA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 182
TABLE 149 CANADA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 183
TABLE 150 CANADA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 183
TABLE 151 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 183
TABLE 152 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 184
9.3 EUROPE 184
9.3.1 EUROPE: RECESSION IMPACT 184
TABLE 153 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 185
TABLE 154 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 185
TABLE 155 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 186
TABLE 156 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 186
TABLE 157 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 186
TABLE 158 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 187
TABLE 159 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 187
TABLE 160 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 187
TABLE 161 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 188
TABLE 162 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 188
TABLE 163 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 188
TABLE 164 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 189
TABLE 165 EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 189
TABLE 166 EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 189
TABLE 167 EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 190
TABLE 168 EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 190
TABLE 169 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 190
TABLE 170 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 191
9.3.2 GERMANY 191
9.3.2.1 Rising government support to drive adoption of AI in medical diagnostics 191
TABLE 171 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 192
TABLE 172 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 192
TABLE 173 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 192
TABLE 174 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 193
TABLE 175 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 193
TABLE 176 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 193
TABLE 177 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 194
TABLE 178 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 194
TABLE 179 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 194
TABLE 180 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 195
TABLE 181 GERMANY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 195
TABLE 182 GERMANY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 195
TABLE 183 GERMANY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 196
TABLE 184 GERMANY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 185 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 196
TABLE 186 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 197
9.3.3 FRANCE 197
9.3.3.1 Availability of funding for companies to enhance AI research in medical imaging 197
TABLE 187 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 198
TABLE 188 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 198
TABLE 189 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 198
TABLE 190 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 199
TABLE 191 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 199
TABLE 192 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 199
TABLE 193 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 200
TABLE 194 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 200
TABLE 195 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 200
TABLE 196 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 201
TABLE 197 FRANCE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 201
TABLE 198 FRANCE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 201
TABLE 199 FRANCE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 202
TABLE 200 FRANCE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 202
TABLE 201 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 202
TABLE 202 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 203
9.3.4 UK 203
9.3.4.1 Increasing radiography procedures to drive market 203
TABLE 203 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 204
TABLE 204 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 204
TABLE 205 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 204
TABLE 206 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 205
TABLE 207 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 205
TABLE 208 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 205
TABLE 209 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 206
TABLE 210 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 206
TABLE 211 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 206
TABLE 212 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 207
TABLE 213 UK: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 207
TABLE 214 UK: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 207
TABLE 215 UK: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 208
TABLE 216 UK: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 208
TABLE 217 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 208
TABLE 218 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 209
9.3.5 ITALY 209
9.3.5.1 Increasing volume of EHRs and EMRs due to rising geriatric population to drive demand for AI solutions 209
TABLE 219 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 209
TABLE 220 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 210
TABLE 221 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 210
TABLE 222 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 210
TABLE 223 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 211
TABLE 224 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 211
TABLE 225 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 211
TABLE 226 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 212
TABLE 227 ITALY: AI IN MEDI
9.3.6 SPAIN 215
9.3.6.1 Growing awareness of AI in Spain to favor market growth 215
TABLE 235 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 215
TABLE 236 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 215
TABLE 237 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 216
TABLE 238 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 216
TABLE 239 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 217
TABLE 240 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 217
TABLE 241 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 217
TABLE 242 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 218
TABLE 243 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 218
TABLE 244 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 218
TABLE 245 SPAIN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 219
TABLE 246 SPAIN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 219
TABLE 247 SPAIN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 219
TABLE 248 SPAIN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 220
TABLE 249 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 220
TABLE 250 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 220
9.3.7 REST OF EUROPE 221
TABLE 251 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 221
TABLE 252 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 221
TABLE 253 REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 222
TABLE 254 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 222
TABLE 255 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 223
TABLE 256 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 223
TABLE 257 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 223
TABLE 258 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 224
TABLE 259 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 224
TABLE 260 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 224
TABLE 261 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225
TABLE 262 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 225
TABLE 263 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225
TABLE 264 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 226
TABLE 265 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 226
TABLE 266 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 226
9.4 ASIA PACIFIC 227
9.4.1 ASIA PACIFIC: RECESSION IMPACT 227
FIGURE 32 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT 228
TABLE 267 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 228
TABLE 268 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 229
TABLE 269 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 229
TABLE 270 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 229
TABLE 271 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 230
TABLE 272 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 230
TABLE 273 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 231
TABLE 274 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 231
TABLE 275 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 231
TABLE 276 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 232
TABLE 277 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 232
TABLE 278 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 232
TABLE 279 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 233
TABLE 280 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 233
TABLE 281 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 233
TABLE 282 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 234
TABLE 283 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 234
TABLE 284 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 234
9.4.2 CHINA 235
9.4.2.1 Rising use of AI in clinical decision-making to drive market 235
TABLE 285 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 235
TABLE 286 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 236
TABLE 287 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 236
TABLE 288 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 236
TABLE 289 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 237
TABLE 290 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 237
TABLE 291 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 237
TABLE 292 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 238
TABLE 293 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 238
TABLE 294 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 238
TABLE 295 CHINA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 239
TABLE 296 CHINA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 239
TABLE 297 CHINA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 239
TABLE 298 CHINA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 240
TABLE 299 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 240
TABLE 300 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 240
9.4.3 JAPAN 241
9.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI solutions 241
TABLE 301 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 241
TABLE 302 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 241
TABLE 303 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 242
TABLE 304 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 242
TABLE 305 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 242
TABLE 306 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 243
TABLE 307 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 243
TABLE 308 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 243
TABLE 309 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 244
TABLE 310 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 244
TABLE 311 JAPAN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 244
TABLE 312 JAPAN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 245
TABLE 313 JAPAN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 245
TABLE 314 JAPAN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 245
TABLE 315 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 246
TABLE 316 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 246
9.4.4 INDIA 246
9.4.4.1 Favorable government initiatives for R&D investments to drive market 246
TABLE 317 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 247
TABLE 318 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 247
TABLE 319 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 248
TABLE 320 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 248
TABLE 321 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 249
TABLE 322 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 249
TABLE 323 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 249
TABLE 324 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 250
TABLE 325 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 250
TABLE 326 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 250
TABLE 327 INDIA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 251
TABLE 328 INDIA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 251
TABLE 329 INDIA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 251
TABLE 330 INDIA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 252
TABLE 331 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 252
TABLE 332 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 252
9.4.5 REST OF ASIA PACIFIC 253
TABLE 333 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 253
TABLE 334 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 253
TABLE 335 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 254
TABLE 336 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 254
TABLE 337 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 255
TABLE 338 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 255
TABLE 339 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 255
TABLE 340 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 256
TABLE 341 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 256
TABLE 342 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 256
TABLE 343 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 257
TABLE 344 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 257
TABLE 345 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 257
TABLE 346 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 258
TABLE 347 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 258
TABLE 348 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 258
9.5 LATIN AMERICA 259
9.5.1 RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS 259
9.5.2 LATIN AMERICA: RECESSION IMPACT 259
TABLE 349 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 259
TABLE 350 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 260
TABLE 351 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 260
TABLE 352 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 260
TABLE 353 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 261
TABLE 354 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 261
TABLE 355 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 261
TABLE 356 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 262
TABLE 357 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021(USD MILLION) 262
TABLE 358 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 262
TABLE 359 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 263
TABLE 360 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 263
TABLE 361 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 263
TABLE 362 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 264
TABLE 363 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 264
TABLE 364 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 264
9.6 MIDDLE EAST & AFRICA 265
9.6.1 GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI 265
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 265
TABLE 365 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 265
TABLE 366 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION) 266
TABLE 367 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION) 266
TABLE 368 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION) 266
TABLE 369 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION) 267
TABLE 370 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION) 267
TABLE 371 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 267
TABLE 372 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION) 268
TABLE 373 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION) 268
TABLE 374 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION) 268
TABLE 375 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION) 269
TABLE 376 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION) 269
TABLE 377 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION) 269
TABLE 378 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION) 270
TABLE 379 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION) 270
TABLE 380 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION) 270
10 COMPETITIVE LANDSCAPE 271
10.1 OVERVIEW 271
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 271
TABLE 381 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 271
10.3 REVENUE ANALYSIS 272
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2017–2022 273
10.4 MARKET SHARE ANALYSIS 273
FIGURE 34 AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022) 273
TABLE 382 AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION 274
FIGURE 35 AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022) 274
10.5 COMPANY EVALUATION MATRIX 275
10.5.1 STARS 275
10.5.2 EMERGING LEADERS 275
10.5.3 PERVASIVE PLAYERS 275
10.5.4 PARTICIPANTS 276
FIGURE 36 AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022 276
10.5.5 COMPANY FOOTPRINT ANALYSIS 276
TABLE 383 OVERALL COMPANY FOOTPRINT (TEN PLAYERS) 276
TABLE 384 APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS) 277
TABLE 385 REGIONAL FOOTPRINT (TEN PLAYERS) 277
10.6 START-UP/SME EVALUATION MATRIX 278
10.6.1 PROGRESSIVE COMPANIES 278
10.6.2 DYNAMIC COMPANIES 278
10.6.3 RESPONSIVE COMPANIES 278
10.6.4 STARTING BLOCKS 278
FIGURE 37 AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022) 279
10.6.5 COMPETITIVE BENCHMARKING 279
TABLE 386 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES 279
TABLE 387 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) 280
10.7 COMPETITIVE SCENARIO 281
10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS 281
TABLE 388 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020–SEPTEMBER 2023 281
10.7.2 DEALS 282
TABLE 389 KEY DEALS, JANUARY 2020–SEPTEMBER 2023 282
10.7.3 OTHER DEVELOPMENTS 283
TABLE 390 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–SEPTEMBER 2023) 283

11 COMPANY PROFILES 284
11.1 KEY PLAYERS 284
(Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)*
11.1.1 MICROSOFT 284
TABLE 391 MICROSOFT: COMPANY OVERVIEW 284
FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022) 285
11.1.2 NVIDIA CORPORATION 289
TABLE 392 NVIDIA CORPORATION: COMPANY OVERVIEW 289
FIGURE 39 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022) 290
11.1.3 MERATIVE 294
TABLE 393 MERATIVE: COMPANY OVERVIEW 294
FIGURE 40 IBM: COMPANY SNAPSHOT (2021) 295
11.1.4 GOOGLE (ALPHABET, INC.) 298
TABLE 394 GOOGLE: COMPANY OVERVIEW 298
FIGURE 41 GOOGLE: COMPANY SNAPSHOT (2022) 299
11.1.5 INTEL CORPORATION 302
TABLE 395 INTEL CORPORATION: COMPANY OVERVIEW 302
FIGURE 42 INTEL CORPORATION: COMPANY SNAPSHOT (2022) 303
11.1.6 SIEMENS HEALTHINEERS 307
TABLE 396 SIEMENS HEALTHINEERS: COMPANY OVERVIEW 307
FIGURE 43 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 308
11.1.7 GE HEALTHCARE 311
TABLE 397 GE HEALTHCARE: COMPANY OVERVIEW 311
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 312
11.1.8 ADVANCED MICRO DEVICES, INC. 316
TABLE 398 ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW 316
FIGURE 45 XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022) 316
11.1.9 KONINKLIJKE PHILIPS N.V. 319
TABLE 399 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 319
FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 320
11.1.10 DIGITAL DIAGNOSTICS, INC. 323
TABLE 400 DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW 323
11.1.11 INFORMAI 326
TABLE 401 INFORMAI: COMPANY OVERVIEW 326
11.2 OTHER PLAYERS 328
11.2.1 HEARTFLOW, INC. 328
11.2.2 ENLITIC, INC. 328
11.2.3 AIDENCE 329
11.2.4 BUTTERFLY NETWORK, INC. 329
11.2.5 NANO X IMAGING LTD. 330
11.2.6 VIZ.AI, INC. 330
11.2.7 QUIBIM 331
11.2.8 QURE.AI 331
11.2.9 THERAPIXEL 332
11.2.10 AIDOC 332
11.2.11 LUNIT, INC. 333
11.2.12 ECHONOUS, INC. 333
11.2.13 ICOMETRIX 334
11.2.14 BRAINOMIX 334
*Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 335
12.1 DISCUSSION GUIDE 335
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 338
12.3 CUSTOMIZATION OPTIONS 340
12.4 RELATED REPORTS 340
12.5 AUTHOR DETAILS 341

★調査レポート[医療診断用人工知能(AI)の世界市場予測(~2028):モダリティ別、用途別、エンドユーザー別] (コード:HIT7875-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療診断用人工知能(AI)の世界市場予測(~2028):モダリティ別、用途別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆